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Synopsis: In this work, we assessed the sensitivity of MP2RAGE at 7T MRI to detect focal cerebellar pathology, 
both in grey and white matter. To do this, we compared cerebellar lesion count in 7T and 3T MP2RAGE images 
in a cohort of MS patients. Lesion detection rate at 7T MRI was higher than the one at 3T, yet the total lesion 
volume was comparable at different field strengths. Lesion volumes calculated on 7T MP2RAGE images 
showed higher correlations with clinical scores than the ones at 3T, pointing at a clinical value of 7T MRI for 
complex regions such as cerebellum. 
Introduction: Multiple Sclerosis (MS) is an autoimmune disease characterized by focal and diffuse brain 
inflammation, degeneration and repair in the central nervous system. Extended demyelination in the cerebellum 
has been shown ex vivo in patients with advanced disease
1
, and a number of recent studies evidenced cerebellar 
grey-matter (GM) and global cerebellar atrophy at various disease stages
2,3
. Nevertheless, while focal white-
matter (WM) pathology in the cerebellum has been extensively investigated, there are only few studies focusing 
on focal cortical cerebellar pathology in vivo
4
. Due to the complex structure of the cerebellum, whose folia are 
made by an inner strip of WM bounded by a thin cortical layer, ultra-high-field MRI might be of benefit to detect 
cerebellar lesions both in WM and in the cortex. In this work, we studied a cohort of early-stage MS patients and 
evaluated the impact of focal cerebellar pathology using MP2RAGE
5,6
 at ultra-high (7T) and high (3T) field 
MRI. Next, we assessed the relationship between cerebellar lesion number and volume, as obtained using 3T and 
7T images, and clinical scores in patients. 
Material and Methods: Nineteen patients (4 males, 15 females, median age 35 years, age range: 21-46 years) 
with early RRMS (disease duration < 5 years from diagnosis) and mild disability (median Expand Disability 
Status Scale-EDSS 1.5, range: 1-2) underwent MR examinations on a 3T (MAGNETOM Trio a Tim system, 
Siemens Healthcare, Germany) and on a research 7T system (Siemens Healthcare, Germany) using a 32-channel 
head coil. From the MRI acquisition protocol, we used the high-resolution Magnetization-Prepared 2 Rapid 
Acquisitions Gradient Echo (MP2RAGE)
6
 with the following parameters: 
 3T: TR/TI1/TI2=5000/700/2500 ms and voxel size = 1.0x1.0x1.2 mm3; 
 7T: TR/TI1/TI2=6000/750/2350 ms and voxel size = 0.75x0.75x0.9 mm3. 
Each subject underwent a neurological examination including the following cognitive and behavioral tests: 1) 
Brief Repeatable Battery of Neuropsychological Tests (BRB-N), which examines verbal and spatial memory, 
sustained attention, information processing speed, and verbal fluency on semantic cues; 2) Multiple Sclerosis 
Functional Composite (MSFC) scores to quantify motor and cognitive performance, and 3) EDSS.  
Cerebellum segmentation was obtained using the MorphoBox
7,8
 prototype. Lesion maps for each patient were 
obtained manually and automatically. Manual detection was performed by two experts (a neurologist and a 
radiologist) in the MP2RAGE image at both 3T and 7T. Automated lesion detection was performed by an in-
house automated tool
9
, only for use in this research study. Total lesion load (TLL), total lesion volume (TLV) 
and mean lesion volume (MLV) per patient were estimated at 3T and 7T. Correlation between cognitive and 
behavioral tests with the TLL, TLV and MLV were performed using the Spearman test adjusted for False 
Discovery Rate (FDR). The performance of the automated segmentation was evaluated for both scenarios using 
a leave-one-out cross validation. Detection rate (DR, number of detected lesions/total manual segmented lesions) 
was obtained for each scenario. Finally, statistical difference was computed using the Wilcoxon signed-rank test.  
  
Results:  Illustration of original data, manual and automated segmentation is reported in Figure 1. We observed 
a significantly higher TLL at 7T compared to 3T (average ± SD, 7T: 9 ± 9 lesions, range: 0 – 31; 3T: 5 ± 8 
lesions, range: 0 - 29, P<0.001, Figure 2). And remarkably, MPRAGE at 7T showed 33% more WM lesions and 
only 5% more GM lesions. The average TLV per patient at 7T was 0.29 ± 0.54 mL (range: 0 - 2.20 mL) and did 
not significantly differ from TLV at 3T (0.29 ± 0.61 mL, range: 0 - 2.54 mL, P=0.231).  However, average MLV 
in the entire patients cohort was lower at 7T (0.022 ± 0.018 mL) compared to 3T (0.041 ± 0.048 mL, P<0.05). 
No correlation was found between the lesion measures at 3T and 7T and motor performance tests. Yet 
interestingly, negative correlations with MLV from manual segmentations on 7T with some cognitive tests 
(SRTR: ρ=-0.5, P=0.0063; SRTD: ρ=-0.7, P=0.0005; VIST: ρ=-0.5, P=0.0068; and VISD: ρ=-0.5, P=0.0069 
after FDR correction, Figure 3) were observed. Automatic detection rates on MP2RAGE images were similar at 
both field strengths (7T: median DR 72%; 3T median DR  67%, P=0.534, Figure 4).  
 
Discussion & Conclusion:  
We have previously shown that the MP2RAGE sequence is sensitive to both WM and GM pathology in MS 
patients
6
. Our current study demonstrates the benefits of using MP2RAGE at ultra-high field to assess the 
presence and clinical impact of cerebellar lesions at early disease stages. MP2RAGE at 7T evidenced a higher 
lesion load than MP2RAGE at 3T, probably due to improved spatial resolution, lower partial-volume effects and 
higher contrast-to-noise. This was significant for manual lesion segmentation but failed to reach significance for 
automated lesion count using an in-house software. Future efforts will be devoted to improve automated lesion 
detection in the cerebellum at 7T by combining MP2RAGE with other contrasts like FLAIR
10
. Notably, 
significant correlations were found between 7T cerebellar lesion volume and verbal and visual memory 
performances in patients, suggesting that 7T MRI may have an important clinical value in multiple sclerosis for 
complex brain regions such as cerebellum. 
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 Figure 1 - Example of a MS patient scanned at 3T (top row) and 7T (bottom row): a. Visualization 3D of the infratentorial 
mask obtained with the MorphoBox prototype; b. 3D rendering of the manual lesion segmentation; c. MP2RAGE image slice 
(sagittal view) of the cerebellum; d. Manual segmentation of cerebellar lesions; e: results of automated segmentation.   
 
 
 Figure 2 - Log-log plot of manual segmentation results in terms of total lesion volume (TLV) and number of lesions obtained 
from 3T (circle) and 7T (triangle) data. Grey and red symbols represent the values per patient and average values, 
respectively.  
 
Figure 3 - Correlation analyses using Spearman's rho between cognitive/behavioral tests and Total Lesion Load (TLL), Total 
Lesion Volume (TLV), and Mean Lesion Volume (MLV) using data sets acquired at 3 and 7T. P-values were adjusted using 
False Discovery Rate (FDR). Significant correlation at uncorrected P-value are identified by *(P<0.05) and **(P<0.001). 
  
 Figure 4 - Boxplots of detection rate (DR) from all patients at 3 and 7T. The dots in the plot represent the values of DR per 
each patient.  
